Cost analysis of depression using the national insurance system in South Korea: a comparison of depression and treatment-resistant depression.

ABSTRACT: BACKGROUND:The incidence and burden of depressive disorders are increasing in South Korea. There are many differences between pharmaceutically treated depression (PTD) and treatment-resistant depression (TRD), including the economic consequences; however, to our knowledge, the economic burden of depression is understudied in South Korea. Therefore, the objective of the present study was to calculate the different economic costs of PTD and TRD in South Korea, specifically by comparing several aspects of medical care. METHODS:This study comprised patients aged 18 and over who were newly prescribed antidepressants for more than 28 days with a depression code included from January 1, 2012, to December 31, 2012, by the Health Insurance Review and Assessment Service (HIRA). TRD was classified as

SUBMITTER: Shin D 

PROVIDER: S-EPMC7137426 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature